Cohort Profile: IAVI's HIV epidemiology and early infection cohort studies in Africa to support vaccine discovery

Affiliations

• ¹ IAVI, New York, USA & Nairobi, Kenya.
• ² Department of Epidemiology and Biostatistics, University of California at San Francisco, San Francisco, CA, USA.
• ³ Rwanda Zambia Emory HIV Research Group, Lusaka & Ndola, Zambia; Kigali, Rwanda.
• ⁴ Emory University, Atlanta, GA, USA.
• ⁵ Medical Research Council, Uganda Virus Research Institute, and London School of Hygiene and Tropical Medicine Uganda Research Unit (MULS), Entebbe & Masaka, Uganda.
• ⁶ Kenyan Medical Research Institute-Wellcome Trust, Kilifi, Kenya.
• ⁷ Nuffield Department of Clinical Medicine, Centre for Clinical Vaccinology and Tropical Medicine, University of Oxford, Headington, UK.
• ⁸ KAVI-Institute of Clinical Research, Nairobi, Kenya.
• ⁹ Department of Pathology and Laboratory Medicine, Emory University, Atlanta, GA, USA.
• ¹⁰ The Aurum Institute, Johannesburg and Rustenburg, South Africa.
• ¹¹ School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
• ¹² Advancing Care and Treatment for TB/HIV, A Collaborating Centre of the South African Medical Research Council, Cape Town, South Africa.
• ¹³ Department of Environmental Health Sciences, Yale School of Public Health, New Haven, CT, USA.
• ¹⁴ Pediatric Infectious Diseases, School of Medicine, Stanford University, Palo Alto, CA, USA.
• ¹⁵ Biostatistics Consultant, Arlington, VA, USA.
• ¹⁶ Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.
• ¹⁷ Desmond Tutu HIV Centre, University of Cape Town, Cape Town, South Africa.
• ¹⁸ Department of Epidemiology, Emory University, Atlanta, GA, USA.
• ¹⁹ IAVI Human Immunology Laboratory, Imperial College, London, UK.
• ²⁰ IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA, USA.
• ²¹ Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA.